首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Informed public debate critical to future of genomic medicine Just mentioning "stem-cell research" or "genomic medicine" can
Informed public debate critical to future of genomic medicine Just mentioning "stem-cell research" or "genomic medicine" can
admin
2012-11-22
49
问题
Informed public debate critical to future of genomic medicine
Just mentioning "stem-cell research" or "genomic medicine" can open a floodgate of beliefs, concerns and, misinformation. Opinions are varied, mixed with fact and fiction, but one thing is clear: Open dialogue among researchers, teachers and the general public must continue as we struggle to define the relationship between our societal values and lifesciences research.
When the University of Washington .and the National Human Genome Research Institute hosted a community genetics forum last spring, questions abounded from the standing-room-only crowd about the implications of genetic research.
When is information about genetic health risks most helpful? Should genetic testing results be part of medical records and how would the results be used potentially by insurance companies? How can genetic testing benefit the criminal-justice system, such as establishings guilt or innocence using DNA testing,
The Human Genome Project will lead to amazing advances in medical science that will result in earlier diagnosis, more-targeted treatment, and a dramatic improvement in our ability to prevent terrible diseases. Genomic medicine will mean more personalized medicine tailored to the individual.
But these advances also carry inherent risks.
The obvious benefits of "personalized medicine" —use of genetic tests to guide preventive care and better drug prescribing—are counterbalanced by the possibility that such tests could lead to discrimination by insurers or employers. And, since genetic risk is often only one of the contributing factors to disease, overemphasis on personalized medicine could burden our health-care system with genetic tests of little or no benefit.
For example, smoking, diet and exercise play major roles in the risk of diabetes and heart disease. Identification of a genetic risk for these diseases can provide specific information for more-effective preventive care, but should not detract from pursuit of a healthy lifestyle.
The greatest health benefits of genomic research likely will come from insights into the basic biology of health and disease. This will ultimately lead to improved prevention and treatment—often without any need for genetic testing—for many diseases. The outcome from this research can be "precision medcine" —a morecost-effective approach to providing high-quality care. Thus, genomic medicine has the potential to improve the value of health care.
An example of the potential of genomic medicine to improve quality and reduce cost is the work of UW researchers Mark Rieder, Allan Rettie and Debbie Nickerson. They recently reported the discovery of a genetic method for accurately determining the proper dosage of a common blood-thinning drug, warfarin, which often produces adverse side effects because of its highly variable activity in patients.
Millions of people worldwide take worldwide to prevent stroke and blood clots, yet require expensive, constant testing from their physician to ensure proper dosage. These scientists’ findings illustrate how the powerful DNA analysis tools of the Human Genome Project are leading to a new era of tailoring drugs and therapies to an individual’s genome. Genomic medicine can lead to more-precise, personalized and cost- effective health care.
Medical advances always involve risk of harm, and genomic medicine is no exception. While technical issues require scientific research, we believe the challenges posed by genetic testing are far too critical to be left to the deliberation of scientists alone.
All members of society should have the opportunity to engage in collaborative discussion about the benefits and harms of genetic testing. Informed public discussion is vital to continue advances that hold so much promise for improving the value of health care.
Both educational resources and major organizational efforts will be needed to create opportunities for open discussion. But the most important resources are people’s time and their willingness to invest it in these discussions.
Researchers, teachers and the media have an obligation to create opportunities for sharing accurate, well-balanced information about potential uses of genomic technology.
Medical advances sometimes involve risk of harm.
选项
A、Y
B、N
C、NG
答案
B
解析
从第十一段第一句可知
转载请注明原文地址:https://jikaoti.com/ti/K8PFFFFM
0
大学英语四级
相关试题推荐
A、Threetimes.B、Fourtimes.C、Sixtimes.D、Seventimes.C细节题。本条新闻报道的是体坛传奇人物阿姆斯特朗Armstrong这位“环法自行车赛”冠军王的采访。通过浏览选项可知,本题考的是“多少次”,听
Themotherwarnedherlittleboynotto______onthefloor,whichshouldbekeptsmooth.
Mostkidswillgothrougha______ofbeingfaddy(追逐)aboutwhattheyeatanddrink.
Thegovernmentthatrefusestomeettheneedsofitspeoplemustbearthe______.
Aprimaryschoolteachercannottakeitforgrantedthathispupilsalwaysdotheirhomework______.
Itishardtopredicthowscienceisgoingtoturnout,andifitisreallygoodscienceitisimpossibletopredict.Ifthethi
A、Workingovertimeasalibrarian.B、Writingpapersforhisclasses.C、Meetingwithhisprofessors.D、Doingextraworkinthech
Sinceancienttimes,thedestructiveeffectsofearthquakesonhumanlivesandpropertyhaveencouragedthesearchforreliable
OnUpdatingKnowledge1.在现代社会,更新知识很重要2.更新知识的途径多种多样3.我的观点
A、Theymustpaymorethanout-of-statestudents.B、Onlyafewareaccepted.C、Theyarenoteligibleforscholarships.D、Theirsc
随机试题
大柴胡汤组成中无
正常骨髓象,幼红细胞约占有核细胞的
仲裁案件当事人甲公司与乙公司在案件仲裁过程中通过协商,就已经提交仲裁的争议达成和解协议。随后申请人甲公司撤回了仲裁申请。后甲公司反悔,此时甲乙两公司的纠纷应如何解决?
某案,正在服刑的被告人向人民法院提起申诉,人民法院审查材料后发现申诉人很可能根本不构成犯罪,于是做出了提起再审的裁定。那么同时还可做什么处理?()
某市甲建筑股份有限公司(增值税小规模纳税人)2012年12月份发生如下业务:(1)自建商品房5000平方米,每平方米建造工程成本2000元,2009年建房时采取预收款方式售出2000平方米,每平方米售价3000元,取得预收款200万元。本月交付房产并
()是建筑的首要目的。
人们在评论超前消费时常用“寅吃卯粮”的比喻,其中“寅”是指()。
①退居二线,摆脱了繁忙的事务,可没过几天______日子,他又闲不住了。②在充分利用原有水利设施的同时,还自力更生______新水源,采取人力、畜力换班,机器不停的办法,昼夜抗旱灌水。③______发展得这样快,我们只有努力学习,加倍工作,
汉字国标GB2312—1980把汉字分成()。
Thetalkswillbeabout______.
最新回复
(
0
)